Navigation Links
New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs
Date:8/5/2008

Leading personal injury law firm representing families of individuals who suffered from suicidal thoughts and erratic behavior while taking popular smoking cessation drug

Mineola, N.Y. (Lexis Nexis) August 5, 2008 - http://thesandersfirm.com/attorney.asp?attorneyid=14 [Marc Grossman], senior partner of leading national personal injury law firm Sanders Viener Grossman LLP, today announced that he has filed five separate product liability lawsuits against Pfizer, Inc., manufacturer of the hugely popular Chantix smoking cessation drug.

The lawsuits (Cases 110517/08, 110518/08, 110519/08, 110520/08 and 110561/08) were filed in the Supreme Court of New York, New York County, and claim that each of the plaintiffs either committed or attempted suicide while suffering from neuropsychiatric side effects that resulted from taking Chantix.

Chantix has been prescribed to more than 6 million people worldwide since its launch in August 2006 and has been approved for use in more than 70 countries as a drug to assist adults who want to quit smoking. However, recent studies have shown that http://thesandersfirm.com/chantix/ [Chantix] may cause serious adverse side effects, such as suicidal thoughts and erratic behavior.

Earlier this year, the U.S. Food and Drug Administration (FDA) issued an alert "to highlight important revisions to the warnings and precautions sections of the prescribing information for Chantix regarding serious neuropsychiatric symptoms."

"We've been investigating claims regarding Chantix ever since the FDA's initial communications about reported side effects, so our firm was well-prepared to vigorously represent our clients when we were contacted by their families," said Grossman. "For those familiar with this year's Tony Award-winning play, 'August: Osage County,' which has sparked debate about the risks of suicide and dysfunction stemming from prescription drug use, the fact that we are filing these actions on the eve of August 1st is a tragic illustration of life imitating art."

The filing of the Chantix lawsuits continues an extremely active year for Sanders Viener Grossman, in which the firm has secured a series of large settlements on behalf of its clients. The firm recently recovered large settlements for approximately 300 plaintiffs involved in the Vioxx-related litigation with Merck & Co. Last month, Sanders Viener Grossman recovered http://thesandersfirm.com/news.asp#article2 [$8 million in damages] for its clients over a span of just eight days, including a $5 million recovery in a product liability case.

According to Grossman, the firm has extensive experience with defective drug litigation and can provide Chantix victims with free consultations and http://thesandersfirm.com/chantix/#form [case reviews] to make sure their legal rights are protected.

For more information about Sanders Viener Grossman LLP, please visit www.thesandersfirm.com or call 1.800.FAIRPLAY.

###

Read the full story at http://www.prweb.com/releases/2008/08/prweb1140624.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Sanderson Farms Launches New Summer Program Encouraging Families to Get Healthy
2. Home Oxygen Community Applauds Senator Bernard Sanders for Joining Bi-Partisan Effort to Formally Oppose Proposed Cuts to Medicares Home Oxygen Benefit
3. DNA Testing and Genetic Profiles Help Avoid Broken Hearts Polls Reveal
4. Sunrise Files 2007 Form 10-K
5. AutoGenomics, Inc. Files Registration Statement for Initial Public Offering
6. Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court
7. The Quantum Group Files TPA Application
8. Noesis Health Introduces AdvancedSMAT for Better Management of Cloverleaf Message Files
9. MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada
10. VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch
11. Sangui BioTech Files Three 2007 Quarterly Reports, Sales Increased, Losses Continue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest ... its plans to open a flagship location in Covington, LA at 401 N. U.S. ... Go store next to Office Depot in the Holiday Square shopping center. Its location ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: